Early surgery better than watchful waiting for patients with severe mitral valve regurgitation

August 13, 2013

Patients with severe mitral valve regurgitation who are otherwise healthy should have mitral valve repair surgery sooner rather than later, even if they feel no symptoms, a Mayo Clinic-led study by U.S. and European researchers found. The results challenge the long-held belief that it is safer to "watch and wait" until a patient has symptoms, such as shortness of breath. This is the largest study to show that patients who undergo surgery early after diagnosis have improved long-term survival and lower risk of heart failure.

The findings will be published Tuesday in the Journal of the American Medical Association.

Mitral valve regurgitation is common and increasing in frequency; it is estimated that by 2030, close to 5 million Americans will have moderate to severe mitral valve regurgitation. It occurs when the mitral valve does not close properly, causing blood to be pumped backward instead of forward. Oxygen-rich blood is thus unable to move through the heart to the rest of the body as efficiently. A heart murmur is often the first sign of mitral valve prolapse. As progresses, symptoms may be absent due to the body's ability to compensate. This initial lack of symptoms preserves quality of life, but prevents patients from being alerted to the seriousness of their condition. One of the most severe complications is heart failure, in which the heart is unable to pump enough blood to the rest of the body, causing , fluid buildup, fatigue and death.

"The results of the current study showed that early surgery provided significant benefits over watchful waiting—and interestingly, were of a magnitude greater than we anticipated," says lead author Rakesh Suri, M.D., D.Phil., a cardiovascular surgeon at Mayo Clinic in Rochester. "This is perhaps counterintuitive. Patients assume they are more severely affected if they need surgery. Actually the opposite is true. Once a patient develops severe mitral valve leakage—even without symptoms—we now know that it is preferable to promptly repair the leakage rather than letting the heart deteriorate.

"Our study shows that the quicker we can stop the leak the better the outcome. In essence early surgery, ideally mitral repair, performed at low risk, is the best way for patients with severe mitral regurgitation to live the longest and to enjoy those years without developing disabling heart failure symptoms."

In the study of 1,021 patients with severe mitral valve regurgitation without symptoms or other classical triggers of surgery, 446 underwent mitral valve repair surgery within three months of diagnosis, while 575 had an initial period of medical monitoring and surgery remained a possible option for the future. The study used the Mitral Regurgitation International Database consisting of participants from six centers in France, Italy, Belgium and the United States. Mayo Clinic was the only U.S. clinical center.

Participants were followed for an average of 10 years, the longest of any study examining when to operate. Long-term survival rates were significantly higher for patients who had surgery within three months of diagnosis than for those who avoided surgery for the initial three months following diagnosis (86 percent versus 69 percent at 10-year follow-up). In addition, long-term risk was lower for patients who had surgery early (7 percent versus 23 percent at 10-year follow-up). There was no difference between the two groups in late-onset atrial fibrillation, another concern for patients with severe mitral valve regurgitation.

Years ago, the risk of surgery and complications was greater, and watchful waiting made more sense, says senior author Maurice Enriquez-Sarano, M.D., a cardiologist at Mayo Clinic in Rochester. But today, specialized high volume valve repair centers centers have a greater than 95 percent success rate for . In addition, the operative risk of death today is less than 1percent, while it was more than 10 times higher in the 1980s, he says.

"The potential benefit of performing surgery to correct the mitral regurgitation before symptoms occur has been hotly debated, and the comparative effectiveness of the surgical and medical approach was previously unknown," Dr. Enriquez-Sarano says. "If is appropriate, depending on age, other conditions and goals in life, we have the opportunity today to eliminate the disease before it gets worse. We can restore life expectancy."

Explore further: Mitral valve repair safe and effective for elderly patients once considered too high risk based on age alone

More information: JAMA. 2013;310(6):609-616
JAMA. 2013;310(6):587-588

Related Stories

Mitral valve repair safe and effective for elderly patients once considered too high risk based on age alone

December 4, 2012
(Medical Xpress)—Heart surgery to repair the mitral valve is safe and leads to a better quality of life for older patients long-suspected to be too high risk for the operation, according to new research from the University ...

Mitral valve repair with bypass surgery may improve heart function

February 29, 2012
Patients who had leaky mitral heart valves repaired along with bypass surgery had with healthier hearts than those who had bypass only, according to new research presented in the American Heart Association's Emerging Science ...

Atrial fibrillation may be root cause of some severe mitral regurgitation cases

September 22, 2011
Mitral regurgitation is a common heart valve disorder, where blood flows backwards through the mitral valve when the heart contracts and reduces the amount of blood that is pumped out to the body. It is a serious condition ...

Effect of MitraClip therapy on mitral regurgitation

August 27, 2012
The percutaneous catheter-based treatment of mitral regurgitation with the MitraClip system improves symptoms and cardiac function at one-year, according to results of a prospective observational study presented here today ...

Improved survival rates for mitral valve heart surgery patients

May 10, 2012
Patients with mitral regurgitation, a type of valvular heart disease common in the elderly, are living longer after surgery, Yale School of Medicine researchers report in the journal Circulation: Cardiovascular Quality and ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.